Literature DB >> 204499

Behavioural despair in rats: a new model sensitive to antidepressant treatments.

R D Porsolt, G Anton, N Blavet, M Jalfre.   

Abstract

Rats when forced to swim in a cylinder from which they cannot escape will, after an initial period of vigorous activity, adopt a characteristic immobile posture which can be readily identified. Immobility was reduced by various clinically effective antidepressant drugs at doses which otherwise decreased spontaneous motor activity in an open field. Antidepressants could thus be distinguished from psychostimulants which decreased immobility at doses which increased general activity. Anxiolytic compounds did not affect immobility whereas major tranquilisers enhanced it. Immobility was also reduced by electroconvulsive shock, REM sleep deprivation and "enrichment" of the environment. It was concluded that immobility reflects a state of lowered mood in the rat which is selectively sensitive to antidepressant treatments. Positive findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacological tests.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204499     DOI: 10.1016/0014-2999(78)90118-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  526 in total

1.  Pargyline conjugate-induced long-term activation of monoamine oxidase as an immunological model for depression.

Authors:  R A Danilova; T A Moskvityna; M F Obukhova; M V Belopolskaya; I P Ashmarin
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

2.  Behavioral despair in mice after prenatal stress.

Authors:  S J Alonso; C Damas; E Navarro
Journal:  J Physiol Biochem       Date:  2000-06       Impact factor: 4.158

3.  Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Douglas W Oliver; Christiaan B Brink
Journal:  Metab Brain Dis       Date:  2010-05-09       Impact factor: 3.584

4.  Maternal separation with early weaning: a novel mouse model of early life neglect.

Authors:  Elizabeth D George; Kelly A Bordner; Hani M Elwafi; Arthur A Simen
Journal:  BMC Neurosci       Date:  2010-09-29       Impact factor: 3.288

5.  In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.

Authors:  Christine DeLorenzo; Matthew S Milak; Kathleen G Brennan; J S Dileep Kumar; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236

6.  Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.

Authors:  Piotr Popik; Martyna Krawczyk; Krystyna Golembiowska; Gabriel Nowak; Aaron Janowsky; Phil Skolnick; Arnold Lippa; Anthony S Basile
Journal:  Cell Mol Neurobiol       Date:  2006-04-25       Impact factor: 5.046

7.  Previous stress increases in vivo biogenic amine response to swim stress.

Authors:  S Jordan; G L Kramer; P K Zukas; F Petty
Journal:  Neurochem Res       Date:  1994-12       Impact factor: 3.996

8.  A pubertal immune challenge alters the antidepressant-like effects of chronic estradiol treatment in inbred and outbred adult female mice.

Authors:  N Ismail; A M Kumlin; J D Blaustein
Journal:  Neuroscience       Date:  2012-10-01       Impact factor: 3.590

9.  Estrous Cycle Phase-Dependent Changes in Anxiety- and Depression-Like Profiles in the Late Adolescent Wistar-Kyoto Rat.

Authors:  Deepthi D'Souza; Monika Sadananda
Journal:  Ann Neurosci       Date:  2017-07-24

10.  Doxycycline Used for Control of Transgene Expression has its Own Effects on Behaviors and Bcl-xL in the Rat Hippocampus.

Authors:  G T Shishkina; D A Lanshakov; A V Bannova; T S Kalinina; N P Agarina; N N Dygalo
Journal:  Cell Mol Neurobiol       Date:  2017-08-31       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.